What is the price of Poolbeg Pharma PLC (POLB)

The price of Poolbeg Pharma PLC (POLB) is $0.11565963

What is the market cap of Poolbeg Pharma PLC (POLB)

The market cap of Poolbeg Pharma PLC (POLB) is $882.99K

Poolbeg Pharma PLC (POLB) Price History

Poolbeg Pharma plc is a clinical-stage biopharmaceutical company based in the United Kingdom, focused on developing treatments for infectious diseases. Its pipeline features several key programs: POLB 001, a p38 MAP Kinase inhibitor intended for severe influenza; POLB 002, a pioneering, in-licensed RNA-based immunotherapy administered intranasally to combat respiratory virus infections; and POLB 003, an intramuscular vaccine aimed at preventing Melioidosis. Beyond specific therapeutic candidates, Poolbeg also holds licensed access to advanced micro- and nanoencapsulation technology for an oral vaccine delivery system designed to stimulate gut immunity. The company further advances its research through an artificial intelligence-powered drug program. Additionally, Poolbeg is developing a biomarker platform to identify individuals at high risk of severe disease, alongside a model-derived vaccine discovery platform to pinpoint novel vaccine candidates. Incorporated in 2021, Poolbeg Pharma plc is headquartered in London.

Year	Performance
2026 (TTM)	28.20%
2025	-42.87%
2024	-20.84%
2023	32.33%
2022	-27.62%
2021	0.00%

Year

Performance

2026 (TTM)

28.20%

2025

-42.87%

2024

-20.84%

2023

32.33%

2022

-27.62%

2021

0.00%

Company	Stock price	Change 1y%	Country
Vertex Pharmaceuticals Incorporated VRTX.US	$508.39	30.26%	US
Argenx SE ARGX.US	$845.14	29.54%	NL
Lonza Group AG LONN.SW	$731.69	7.13%	CH
Samsung Biologics Co.,Ltd. 207940.KS	$1.07K	-6.40%	KR
UCB S.A. UCB.BR	$251.82	11.25%	BE

Company

Stock price

Change 1y%

Country